Astrazeneca (AZN) EBT Margin (2009 - 2026)
Astrazeneca (AZN) reported EBT Margin of 26.27% for Q3 2026, up 3.69 percentage points from 22.58% a year earlier and up 8.08 percentage points from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) EBT Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Astrazeneca's EBT Margin came in at 22.40%, up 1.62 percentage points year-over-year; for FY2025, it came in at 21.11%, up 5.04 percentage points from FY2024.
- EBT Margin has increased for four consecutive years, with a five-year change of +6.40 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at 16.07% in FY2024 (+1.01 pp), 15.06% in FY2023 (+9.42 pp), 5.64% in FY2022 (+6.35 pp) and -0.71% in FY2021 (-15.42 pp).
- Five-year quarterly EBT Margin spans a low of -5.53% in Q4 2021 and a high of 27.21% in Q1 2026.
- Year over year, EBT Margin gained in seven of the last eight quarters, with an average year-over-year change of +3.27 percentage points.
- The high point for year-over-year EBT Margin in five years was Q3 2022 (a gain of 28.94 percentage points); the low point was Q4 2021 (a drop of 22.18 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at 18.19% (Q2 2026), 27.21% (Q1 2026) and 18.08% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 20.41% |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 22.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 26.27% |
| Jun 30, 2026 | 18.19% |
| Mar 31, 2026 | 27.21% |
| Dec 31, 2025 | 18.08% |
| Sep 30, 2025 | 22.58% |
| Jun 30, 2025 | 21.63% |
| Mar 31, 2025 | 26.42% |
| Dec 31, 2024 | 12.47% |
| Sep 30, 2024 | 14.12% |
| Jun 30, 2024 | 18.53% |
| Mar 31, 2024 | 22.99% |
| Dec 31, 2023 | 7.92% |
| Sep 30, 2023 | 14.99% |
| Jun 30, 2023 | 18.29% |
| Mar 31, 2023 | 21.41% |
| Dec 31, 2022 | 6.94% |
| Sep 30, 2022 | 8.40% |
| Jun 30, 2022 | 2.29% |
| Mar 31, 2022 | 4.86% |
| Dec 31, 2021 | -5.53% |
API Access
Astrazeneca EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();